Form 4: CVS Health Executive Tilak Mandadi Reports Stock Transactions

EVP Tilak Mandadi reports acquisition of restricted stock units and stock options, along with the surrender of shares for tax withholding.

Summary

• Tilak Mandadi, EVP, Chief Experience & Tech at CVS Health Corp, reported transactions involving CVS stock on April 1, 2025.
• Mandadi surrendered 995 shares of common stock at $67.98 per share to cover withholding taxes related to vesting restricted stock units.
• He also acquired 20,594 restricted stock units (RSUs) at a price of $67.98, which vest in four equal annual installments starting April 1, 2026.
• Additionally, Mandadi acquired stock options for 87,336 shares of common stock at an exercise price of $67.98, which become exercisable in four equal annual installments starting April 1, 2026.
• Following these transactions, Mandadi directly owns 43,503 shares of common stock and 116,257 restricted stock units, and holds options for 87,336 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing detailing stock transactions. The acquisition of RSUs and options could be seen as a positive sign of confidence, but it's a routine part of executive compensation.

Positives

• The acquisition of RSUs and stock options suggests confidence in CVS Health's future performance.

Future Outlook

The vesting schedule of the RSUs and the exercisability of the stock options suggest a long-term incentive plan for the executive, aligning his interests with the company's performance over the next several years.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. They provide insights into the actions of company executives and their confidence in the company's stock.

Comparison to Industry Standards

• Executive compensation packages often include a mix of salary, stock options, and restricted stock units to incentivize performance and align executive interests with shareholder value.
• Vesting schedules for RSUs and stock options are common, typically spanning several years to encourage long-term commitment.
• The specific terms of Mandadi's compensation package (number of shares, vesting schedule, exercise price) would need to be compared to those of executives at peer companies like Walgreens Boots Alliance (WBA) and UnitedHealth Group (UNH) to assess its competitiveness.

Stakeholder Impact

• The transactions themselves have minimal direct impact on stakeholders.
• However, the vesting of RSUs and exercisability of stock options incentivize the executive to drive long-term value for shareholders.

Key Dates

Keywords

CVS Health, Tilak Mandadi, stock options, restricted stock units, Form 4, insider trading, executive compensation, stock transactions